ChromaCode expands the number of samples a lab can process when using the same equipment and lab technicians, without sacrificing accuracy.
Delfi Diagnostics detects cancer sooner, enabling the most informed treatment decision.
Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.
Inflammatix develops rapid tests to read a patient’s immune system to better characterize diseases, such as sepsis and fever of unknown origin.
Octave is developing an integrated care management platform for multiple sclerosis (MS) and other neurodegenerative diseases.
Personal Genome Diagnostics (PGDx) provides advanced cancer genome analysis to help clinicians and researchers provide more informed treatment selection, sooner.
Scipher has built a diagnostic platform that analyzes a patient’s individual molecular data to ensure optimal therapy is prescribed.
Selux is developing a rapid solution for antibiotic susceptibility testing, which affects millions of patients who suffer from infection when resistant to available antibiotics.
Sherlock is developing a molecular diagnostics platform that enables instrument-free, simple-to-operate tests that can be applied across multiple diseases and in both clinical and non-clinical settings.
SpeeDx developed a diagnostics platform, principally for infectious diseases, that provides both identification and therapeutic guidance capabilities in the same simplified workflow.
Torus Biosystems created a multiplex syndromic testing system, giving clinicians the necessary tools to rapidly diagnose infectious diseases at the point of care.
Vital Bio is reimagining the status quo of lab testing through an ecosystem of diagnostic tools that enable patients to get real-time care that is accessible and empowering.